PLAT and stroke disorder: Initially, NXY-059 was hailed as a stroke neuroprotectant success, fulfilling significant results in pre-clinical STAIR criteria including BBB permeability, efficacy in two or more laboratories, neuroprotection, functional improvement, functionally adjuvant with tPA, and randomized, blinded studies.